Effect of Sepsis Response Team in the Emergency Department
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03789838|
Recruitment Status : Completed
First Posted : December 31, 2018
Last Update Posted : December 31, 2018
|Condition or disease||Intervention/treatment|
|Sepsis||Other: Sepsis rapid response team|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||245 participants|
|Target Follow-Up Duration:||1 Year|
|Official Title:||Prospective Cohort Study Examining the Effect of a Sepsis Rapid Response Team in the Emergency Department|
|Actual Study Start Date :||May 15, 2017|
|Actual Primary Completion Date :||May 15, 2018|
|Actual Study Completion Date :||May 15, 2018|
Before of sepsis rapid response team
Time from arrival at the Emergency Department to antibiotic is administered, before introduction of sepsis response team in the Emergency Department.
Sepsis rapid response team
Time from arrival at the Emergency Department to antibiotic is administered, with sepsis response team in the Emergency Department.
Other: Sepsis rapid response team
Patients with suspected sepsis is managed by a sepsis rapid response team in a structured manner.
- Time from arrival the emergency department to antibiotic is given. [ Time Frame: 6 months ]Time from arrival the emergency department to antibiotic is given.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03789838
|Oslo University Hospital|
|Oslo, Norway, 0424|
|Principal Investigator:||Aleksander Holten, Phd, MD||Oslo University Hospital|